Sat, May 25, 2013, 2:21 PM EDT - U.S. Markets closed
IRWD has executed a masterful partnering strategy that now gives worldwide reach for linaclotide. To review:
Forest - US, Canada, Mexico
Almirall - Europe, Russia, Turkey, Switzerland
Astellas - Japan, Korea, Taiwan, Phillippines, Indonesia
AstraZeneca - China
They are also building the early stage pipeline through deals like the one announced today. Linaclotide is expected to be a billion dollar drug, and we will be seeing increasing revs with profitability late next year.